Legend Biotech Corp. (LEGN)
22.16
-0.16
(-0.74%)
USD |
NASDAQ |
Dec 15, 13:47
Legend Biotech Shareholders Equity (Quarterly): 1.011B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CorMedix, Inc. | 374.13M |
| Exelixis, Inc. | 2.161B |
| Abeona Therapeutics, Inc. | 171.23M |
| Akero Therapeutics, Inc. | 957.64M |
| Cabaletta Bio, Inc. | 139.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.713B |
| Total Liabilities (Quarterly) | 693.56M |
| Debt to Equity Ratio | 0.4057 |
| Current Ratio | 2.865 |
| Net Debt Paydown Yield | -0.24% |